首页> 中文期刊> 《临床肺科杂志》 >酶联免疫斑点试验检测技术(Elispot)在诊断结核性脑膜炎及Ⅲ型肺结核中的应用价值

酶联免疫斑点试验检测技术(Elispot)在诊断结核性脑膜炎及Ⅲ型肺结核中的应用价值

         

摘要

Objective To investigate mycobacterium tuberculosis antigen specific IFN-r response(Elispot) in patients with tuberculous meningeencephalitis or Ⅲ type pulmonary turberculesis. Methods 383 cases of tuberculosis patients ( including 73 cases of tuberculous meningeencephalitis and 310 cases of Ⅲ type pulmonary turberculesis ) and 97 bealthy volunteers were enrolled in our study. The antigen specific IFN-r responses were evaluated by Elispot assay. Results The sensibility of Elispot in tuberculosis patients is 81.64%,and the specificity is 85.57%. Positive IFN-r response were detected in 61.64% tuberculous meningeencephalitis group, 86.13% in Ⅲ type pulmonary turbercuiosis group and 10.31% in healthy wolunteers. There were statistical differences between groups( P < 0. 05 ).Conclusion Antigen-specific IFN-r Elispot assay could be a favourable assistant method in the diagnosis of Tuberculosis. It has better value in Ⅲ type pulmonary tuberculosis than in tuberculous meningeencephalitis.%目的 评价酶联免疫斑点技术(Elispot)检测外周血结核杆菌抗原特异性r干扰素(IFN-r)水平在结核脑膜脑炎及Ⅲ型肺结核患者诊断中的应用价值.方法 利用Elispot技术分别对383例结核病人(包括73例结核性脑膜炎患者、310例Ⅲ型肺结核患者)、97例健康人外周血结核杆菌抗原特异性r干扰素(IFN-r)水平进行定量检测.结果 Elispot技术在结核病中诊断敏感性为81.46%,特异性为85.57%;结核脑膜脑炎组Elispot阳性率为61.64%;Ⅲ型肺结核患者组Elispot阳性率为86.13%;健康对照组Elispot阳性率为10.31%;各组间比较差异具有统计学意义(P<0.05).结论 Elispot技术在结核病诊断中具有良好的辅助诊断价值,在Ⅲ型肺结核中的诊断价值优于结核性脑膜脑炎.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号